Insider Transactions in Q4 2024 at Ocular Therapeutix, Inc (OCUL)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 25
2024
|
Peter Kaiser Chief Development Officer |
SELL
Open market or private sale
|
Direct |
2,897
-1.34%
|
$26,073
$9.01 P/Share
|
|
Nov 25
2024
|
Jeffrey S. Heier Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,948
-1.08%
|
$26,532
$9.01 P/Share
|
|
Nov 25
2024
|
Pravin Dugel Director |
SELL
Open market or private sale
|
Direct |
20,680
-2.55%
|
$186,120
$9.01 P/Share
|
|
Nov 25
2024
|
Sanjay Nayak Chief Strategy Officer |
SELL
Open market or private sale
|
Direct |
1,814
-1.03%
|
$16,326
$9.0 P/Share
|
|
Oct 07
2024
|
Todd Anderman Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
98,700
+50.0%
|
-
|
|
Oct 02
2024
|
Jeffrey S. Heier Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+26.88%
|
-
|
|
Oct 02
2024
|
Peter Kaiser Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+31.65%
|
-
|